Robust QSAR models using bayesian regularized neural networks

Journal of Medicinal Chemistry

Volumn 42, Issue 16, 1999, Pages 3183-3187

  Burden, Frank R ^a   Winkler, David A ^b  

^a MONASH UNIVERSITY   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR; DIAZEPAM; MUSCARINIC AGENT; MUSCARINIC RECEPTOR;

ARTICLE; ARTIFICIAL NEURAL NETWORK; MOLECULAR MODEL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; VALIDATION PROCESS;

DRUG DESIGN; NEURAL NETWORKS (COMPUTER); REGRESSION ANALYSIS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0033549850     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980697n     Document Type: Article

References (38)

1. Hansch, C.; Fujita, T. ρ-σ-π Analysis. A Method for the Correlation of Biological Activity and Chemical Structure. J. Am. Chem. Soc. 1964, 86, 1616.
2. (a) Hadamard, J. Sur les problemes aux derivees parielies et leur signification physique. Bull. Univ. Princeton 1902, 49-52.
3. (b) Tikhonov, A.; Arsenin, V. Solution of Ill-posed Problems; Winston: Washington, DC, 1977.
4. Goutte, C. Statistical Learning and Regularization for Regression. Ph.D. Thesis, University of Paris, 1997.
5. Ajay; Walters, W. P.; Murcko, M. Can we Learn to Distinguish between "Drug-like" and "Nondrug-like" Molecules? J. Med. Chem. 1998, 41, 3314-3324.
6. Randic, M. On Characterization of Molecular Branching. J. Am. Chem. Soc. 1975, 97, 6609-6615.
7. Kier, L. B.; Hall, L. H. The Molecular Connectivity Chi Indexes and kappa Shape Indexes in Structure-Property Modelling. In Reviews in Computational Chemistry; Lipkowitz, K. B., Boyd, D. B., Eds.; VCH Publishers: New York, 1995; Vol. 2, pp 367-422 and references therein.
8. Burden, F. R. Using Artificial Neural Networks to Predict Biological Activity from Simple Molecular Strctural considerations. Quant. Struct.-Act. Relat. 1996, 15, 7-11.
9. Winkler, D. A.; Burden, F. R.; Watkins, A. J. R. Atomistic Topological Indices Applied to Benzodiazepines using Various Regression Methods. Quant. Struct.-Act. Relat. 1998, 17, 14-19.
10. MacKay, D. J. C. A Practical Bayesian Framework for Backprop Networks. Neural Comput. 1992, 4, 415-447.
11. (b) Mackay, D. J. C. Probable Networks and Plausible Predictions - a Review of Practical Bayesian Methods for Supervised Neural Networks, Comput. Neural Sys. 1995, 6, 469-505.
12. (c) Mackay, D. J. C. Bayesian Interpolation. Neural Comput. 1992, 4, 415-447.
13. Buntine, W. L.; Weigend, A. S. Bayesian Back-Propagation. Complex Sys. 1991, 5, 603-643.
14. MATLAB; The MathWorks, Inc.: Natick.
15. Hagen, M. T.; Menhaj, M. Training Feedforward Networks With The Marquardt Algorithm. IEEE Trans. Neural Networks 1994, 5, 989-993.
16. A Receptors Using Neural Networks. J. Med. Chem. 1995, 38, 715-724.
17. (a) Blair, T.; Webb, G. A. Electronic Factors in the Structure-Activity Relationship of Some 1,4-Benzodiazepin-2-ones. J. Med. Chem. 1977, 20, 1206-1210.
18. (b) Greco, G.; Novellino, E.; Silipo, C.; Vittoria, A. Study of Benzodiazepines Receptor Sites Using Combined QSAR-CoMFA Approach. Quant. Struct.-Act. Relat. 1992, 11, 461-477.
19. (c) Gupta, S. P.; Paleti, A. Quantitative Structure-Activity relationship Studies on Benzodiazepine Receptor Binding of Some Nonbenzodiazepine Series of Ligands. Quant. Struct.-Act. Relat. 1996, 15, 12-16.
20. (d) Gupta, S. P. QSAR Studies on Drugs Acting at the Central Nervous System. Chem. Rev. 1989, 89, 1765-1800.
21. Haefely, W.; Kyburz, E.; Gerecke, M.; Möhler, H. Recent Advances in the Molecular Pharmacology of Benzodiazepine Receptors and the Structure-Activity Relationships of their Agonists and Antagonists. Adv. Drug Res. 1985, 14, 165-322.
22. Harrison, P. W.; Barlin, G. B.; Davies, L. P.; Ireland, S. J.; Matyus, P.; Wong, M. G. Syntheses, pharmacological evaluation and molecular modelling of substituted 6-alkoxyimidazo[1,2-b]-pyridazines as new ligands for the benzodiazepine receptor. Eur. J. Med. Chem. 1996, 31, 651-662.
23. Davies, L. P.; Barlin, G. B.; Ireland, S. J.; Ngu, M. M. L. Substituted imidazo[1,2-β]pyridazines. New compounds with activity at central and peripheral benzodiazepine receptors. Biochem. Pharmacol. 1992, 44, 1555-1561.
24. Barlin, G. B.; Davies, L. P.; Davis, R. A.; Harrison, P. W. Imidazo-[1,2-β]pyridazines. XVII* Synthesis and central nervous system activity of some 6-(alkylthio and chloro)-3-(methoxy, unsubstituted and benzamidomethyl)-2-aryl-imidazo[1,2-β]pyridazines containing methoxy, methylenedioxy and methyl substituents. Aust. J. Chem. 1994, 47, 2001-2012.
25. Fryer, R. I.; Zhang, P.; Rios, R.; Gu, Z.-Q.; Basile, A. S.; Skolnick, P. Structure-activity relationship studies at the benzodiazepine receptor (BzR): A comparison of the substituent effects of pyrazoloquinoline analogues. J. Med. Chem. 1993, 36, 1669-1673.
26. Wang, C.-G.; Langer, T.; Kamath, P. G.; Gu, Z.-Q.; Skolnick, P.; Fryer, R. I. Computer-aided molecular modelling, synthesis and biological evaluation of 8-(benzyloxy)-2-phenylpyrazolo[4,3-c]-quinoline as a novel benzodiazepine receptor agonist ligand. J. Med. Chem. 1995, 38, 950-957.
27. Hollinshead, S. P.; Trudell, M. L.; Skolnick, P.; Cook, J. M. Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester. J. Med. Chem. 1990, 33, 1062-1069.
28. Allen, M. S.; Hagen, T. J.; Trudell, M. L.; Codding, P. W.; Skolnick, P.; Cook, J. M. Synthesis of novel 3-substituted b-carbolines as benzodiazepine receptor ligands: Probing the benzodiazepine pharmacophore. J. Med. Chem. 1988, 31, 1854-1861.
29. Yokoyama, N.; Ritter, B.; Neubert, A. D. 2-Arylpyrazolo[4,3-c]-quinolin-3-ones: Novel agonist, partial agonist and antagonist benzodiazepines. J. Med. Chem. 1982, 26, 337-339.
30. Orlek, B. S.; Blaney, F. E.; Brown, F.; Clark, M. S. G.; Hadley, M. S.; Hatcher, J.; Riley, G. J.; Rosenberg, H. E.; Wadsworth, H. J.; Wyman, P. Comparison of Azabicyclic Esters and Oxadiazoles as Ligands for the Muscarinic Receptor. J. Med. Chem. 1991, 34, 2726-2735
31. Wadsworth, H. J.; Jenkins, S. M.; Orlek, B. S.; Cassidy, F.; Clark, M. S. G.; Brown, F.; Riley, G. J.; Graves, D.; Hawkins, J.; Naylor, C. Synthesis and Muscarinic Activity of Quinuclidin-3-yltriazole and -tetrazole Derivatives. J. Med. Chem., 1992, 35, 1280-1290.
32. Ward, J. S.; Merritt, L.; Klimkowski, V. J.; Lamb, M. L.; Mitch, C. H.; Bymaster, F. P.; Sawyer, B.; Shannon, H. E.; Olesen, P. H.; Honoré, T.; Sheardown, M. J.; Sauerberg, P. Novel functional Ml selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore. J. Med. Chem. 1992, 35, 4011-4019.
33. Sauerberg, P.; Olesen, P. H.; Nielsen, S.; Treppendahl, S.; Sheardown, M. J.; Honoré, T.; Mitch, C. H.; Ward, J. S.; Pike, A. J.; Bymaster, F. P.; Sawyer, B. D.; Shannon, H. E. Novel functional M1 selective muscarinic agonists. Synthesis and structure-activity relationships of 3-(1,2,5-thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines. J. Med. Chem. 1992, 35, 2274-2283.
34. Jenkins, S. M.; Wadsworth, H. J.; Bromidge, S.; Orlek, B. S.; Wyman, P. A.; Wiley, G. J.; Hawkins, J. Substituent Variation in Azabicyclic Triazole and Tetrazole-Based Muscarinic Receptor Ligands. J. Med. Chem. 1991, 35, 2392-2406.
35. Sauerberg, P.; Kindtlet, J. W.; Nielsen, L.; Sheardown, M. J.; Honoré, T. Muscarinic Cholinergic Agonists and Antagonists of the 3-(3-Alkyl-1,2,4-oxadiazol-5-yl-1,2,5,6-Tetrahydropyridine Type. Synthesis and Structure-Activity Relationships. J. Med. Chem. 1991, 34, 687-692.
36. PLS Toolbox version 1.5, Eigenvalue Research Inc.
37. Manallack, D. T.; Livingstone, D. J. Artificial Neural Networks: Application and Chance Effects for QSAR Data Analysis. Med. Chem. Res. 1992, 2, 181-190.
38. A Receptors. J. Med. Chem. 1996, 39, 5246-5256.